Company Filing History:
Years Active: 2007
Title: Franz-Josef Kramer: Innovator in Osteoanabolic Medicaments
Introduction
Franz-Josef Kramer is a notable inventor based in Springe, Germany. He has made significant contributions to the field of medicine, particularly in the area of bone health. His innovative work focuses on the development of medicaments that enhance bone regeneration and treat various bone-related conditions.
Latest Patents
Franz-Josef Kramer holds a patent for a medicament containing a tissue inhibitor of metalloproteinases-2 (TIMP-2) as an osteoanabolically active substance. This invention relates to the use of TIMP-2 as an osteoanabolically active peptide for treating bone defects and diseases, as well as for improving bone regeneration. The patent highlights the potential of TIMP-2 in advancing therapeutic options for patients suffering from bone-related ailments.
Career Highlights
Kramer is associated with Ipf Pharmaceuticals GmbH, where he continues to work on innovative solutions in the pharmaceutical industry. His dedication to research and development has positioned him as a key figure in the advancement of osteoanabolic therapies.
Collaborations
Franz-Josef Kramer collaborates with esteemed colleagues, including Silke Mark and Ludger Ständker. Their combined expertise contributes to the ongoing research and development efforts at Ipf Pharmaceuticals GmbH.
Conclusion
Franz-Josef Kramer is a pioneering inventor whose work in osteoanabolic medicaments has the potential to significantly impact the treatment of bone diseases and enhance bone regeneration. His contributions to the field are invaluable and continue to inspire advancements in medical science.